USPTO serial 79115014
FROM DISCOVERY TO CURE
Reviewed by CopyMark Law Group
Reg. 4366418Status 706Registered
- Filing date
- Status date
- Registration date
- Jul 16, 2013
- Examiner
- TWOHIG, SHANNON MARIE
- Law office
- TMO LAW OFFICE 121
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with FROM DISCOVERY TO CURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patricia A. Walker
Patricia A. Walker Walker & Jocke Co., LPA231 South BroadwayMEDINA, OH 44256-2601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans | ACTIVE | — |
| 041 | Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and related medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children | ACTIVE | — |
| 042 | Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children | ACTIVE | — |
| 044 | Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Prof. Dr. jur. Andreas Staudacher
- Other trademarks owned by Prof. Dr. jur. Andreas Staudacher
- Other trademarks owned by Prof. Dr. jur. Andreas Staudacher
- Other trademarks owned by Prof. Dr. Dr. Christoph Klein
- Other trademarks owned by Prof. Dr. Dr. Christoph Klein
- Other trademarks owned by Prof. Dr. Dr. Christoph Klein
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named FROM DISCOVERY TO CURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 11, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 11, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Mar 25, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2023 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Sep 16, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 9, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 14, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 16, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jan 20, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 23, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 23, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 21, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 20, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 20, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 20, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 20, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Dec 28, 2019 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Nov 1, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 3, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 27, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 21, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 13, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 25, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 25, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 16, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 16, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 30, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 10, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 10, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 22, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 18, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2013 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 15, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 13, 2013 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 10, 2013 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 25, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 24, 2013 | ALIE | ASSIGNED TO LIE | — |
| Feb 13, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2013 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 12, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 12, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 8, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 8, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 8, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 7, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 2, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |